Literature DB >> 17289789

Pharmacological dissection of the human gastro-oesophageal segment into three sphincteric components.

James G Brasseur1, Rhys Ulerich, Qing Dai, Dalipkumar K Patel, Ahmed M S Soliman, Larry S Miller.   

Abstract

Quantifications of gastro-oesophageal anatomy in cadavers have led some to identify the lower oesophageal sphincter (LOS) with the anatomical gastric sling-clasp fibres at the oesophago-cardiac junction (OCJ). However, in vivo studies have led others to argue for two overlapping components proximally displaced from the OCJ: an extrinsic crural sphincter of skeletal muscle and an intrinsic physiological sphincter of circular smooth-muscle fibres within the abdominal oesophagus. Our aims were to separate and quantify in vivo the skeletal and smooth muscle sphincteric components pharmacologically and clarify the description of the LOS. In two protocols an endoluminal ultrasound-manometry assembly was drawn through the human gastro-oesophageal segment to correlate sphincteric pressure with the anatomic crus. In protocol I, fifteen normal subjects maintained the costal diaphragm at inferior/superior positions by full inspiration/expiration (FI/FE) during pull-throughs. These were repeated after administering atropine to suppress the cholinergic smooth-muscle sphincter. The cholinergic component was reconstructed by subtracting the atropine-resistant pressures from the full pressures, referenced to the anatomic crus. To evaluate the extent to which the cholinergic contribution approximated the full smooth-muscle sphincter, in protocol II seven patients undergoing general anaesthesia for non-oesophageal pathology were administered cisatracurium to paralyse the crus. The smooth-muscle sphincter pressures were measured after lung inflation to approximate FI. The cholinergic smooth-muscle pressure profile in protocol I (FI) matched closely the post-cisatracurium smooth-muscle pressure profile in protocol II, and the atropine-resistant pressure profiles correlated spatially with the crural sling during diaphragmatic displacement. Thus, the atropine-resistant and cholinergic pressure contributions in protocol I approximated the skeletal and smooth muscle sphincteric components. The smooth-muscle pressures had well-defined upper and lower peaks. The upper peak overlapped and displaced rigidly with the crural sling, while the distal peak separated from the crus/upper-peak by 1.1 cm between FI and FE. These results suggest the existence of separate upper and lower intrinsic smooth-muscle components. The 'upper LOS' overlaps and displaces with the crural sling consistent with a physiological LOS. The distal smooth-muscle pressure peak defines a 'lower LOS' that likely reflects the gastric sling/clasp muscle fibres at the OCJ. The distinct physiology of these three components may underlie aspects of normal sphincteric function, and complexity of sphincter dysfunction.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17289789      PMCID: PMC2075459          DOI: 10.1113/jphysiol.2006.124032

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  37 in total

1.  Diaphragmatic contribution to gastroesophageal competence and reflux in dogs.

Authors:  C J Martin; W J Dodds; H H Liem; R O Dantas; R D layman; J Dent
Journal:  Am J Physiol       Date:  1992-10

2.  The gastroesophageal sphincter in healthy human beings.

Authors:  C F CODE; F E FYKE; J F SCHLEGEL
Journal:  Gastroenterologia       Date:  1956

3.  Atropine inhibits gastric distension and pharyngeal receptor mediated lower oesophageal sphincter relaxation.

Authors:  R K Mittal; C Chiareli; J Liu; R H Holloway; W Dixon
Journal:  Gut       Date:  1997-09       Impact factor: 23.059

4.  Mechanism of gastroesophageal reflux in recumbent asymptomatic human subjects.

Authors:  J Dent; W J Dodds; R H Friedman; T Sekiguchi; W J Hogan; R C Arndorfer; D J Petrie
Journal:  J Clin Invest       Date:  1980-02       Impact factor: 14.808

5.  The effects of cricoid pressure, remifentanil, and propofol on esophageal motility and the lower esophageal sphincter.

Authors:  Kristian Thorn; Sven-Egron Thorn; Magnus Wattwil
Journal:  Anesth Analg       Date:  2005-04       Impact factor: 5.108

6.  Effect of atropine on the frequency of reflux and transient lower esophageal sphincter relaxation in normal subjects.

Authors:  R K Mittal; R Holloway; J Dent
Journal:  Gastroenterology       Date:  1995-11       Impact factor: 22.682

7.  Integrity of cholinergic innervation to the lower esophageal sphincter in achalasia.

Authors:  R H Holloway; W J Dodds; J F Helm; W J Hogan; J Dent; R C Arndorfer
Journal:  Gastroenterology       Date:  1986-04       Impact factor: 22.682

8.  Effects of sevoflurane and enflurane on lower esophageal sphincter pressure and gastroesophageal pressure gradient in children.

Authors:  A Kohjitani; J Shirakawa; E Satoh; T Kagawa; M Nakajima; H Obara
Journal:  J Anesth       Date:  1999       Impact factor: 2.078

9.  Muscular equivalent of the lower esophageal sphincter.

Authors:  D Liebermann-Meffert; M Allgöwer; P Schmid; A L Blum
Journal:  Gastroenterology       Date:  1979-01       Impact factor: 22.682

10.  Effect of atropine on esophageal motor function in humans.

Authors:  W J Dodds; J Dent; W J Hogan; R C Arndorfer
Journal:  Am J Physiol       Date:  1981-04
View more
  28 in total

1.  Pressure morphology of the relaxed lower esophageal sphincter: the formation and collapse of the phrenic ampulla.

Authors:  Monika A Kwiatek; Frédéric Nicodème; John E Pandolfino; Peter J Kahrilas
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-11-23       Impact factor: 4.052

2.  The esophagogastric junction.

Authors:  Larry S Miller; Anil K Vegesna; James G Brasseur; Alan S Braverman; Michael R Ruggieri
Journal:  Ann N Y Acad Sci       Date:  2011-09       Impact factor: 5.691

Review 3.  Biomechanics of the esophagogastric junction in gastroesophageal reflux disease.

Authors:  Sudip K Ghosh
Journal:  Curr Gastroenterol Rep       Date:  2008-06

4.  Measuring length-tension function of the anal sphincters and puborectalis muscle using the functional luminal imaging probe.

Authors:  Lori J Tuttle; Ali Zifan; Catherine Sun; Jessica Swartz; Sophia Roalkvam; Ravinder K Mittal
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-08-30       Impact factor: 4.052

5.  Characterization of the distal esophagus high-pressure zone with manometry, ultrasound and micro-computed tomography.

Authors:  A K Vegesna; J A Sloan; B Singh; S J Phillips; A S Braverman; M F Barbe; M R Ruggieri; L S Miller
Journal:  Neurogastroenterol Motil       Date:  2012-09-24       Impact factor: 3.598

Review 6.  Physiology of the upper segment, body, and lower segment of the esophagus.

Authors:  Larry Miller; Pere Clavé; Ricard Farré; Begoña Lecea; Michael R Ruggieri; Ann Ouyang; Julie Regan; Barry P McMahon
Journal:  Ann N Y Acad Sci       Date:  2013-10       Impact factor: 5.691

7.  First Experience with Banded Anti-reflux Mucosectomy (ARMS) for GERD: Feasibility, Safety, and Technique (with Video).

Authors:  Herbert Mason Hedberg; Kristine Kuchta; Michael B Ujiki
Journal:  J Gastrointest Surg       Date:  2019-02-07       Impact factor: 3.452

8.  Enhanced nicotinic receptor mediated relaxations in gastroesophageal muscle fibers from Barrett's esophagus patients.

Authors:  L S Miller; A K Vegesna; A S Braverman; M F Barbe; M R Ruggieri
Journal:  Neurogastroenterol Motil       Date:  2013-12-15       Impact factor: 3.598

9.  Vagal afferent innervation of the lower esophageal sphincter.

Authors:  Terry L Powley; Elizabeth A Baronowsky; Jared M Gilbert; Cherie N Hudson; Felecia N Martin; Jacqueline K Mason; Jennifer L McAdams; Robert J Phillips
Journal:  Auton Neurosci       Date:  2013-04-11       Impact factor: 3.145

10.  Induced opening of the gastroesophageal junction occurs at a lower gastric pressure in gerd patients and in hiatal hernia subjects than in normal control subjects.

Authors:  Anil Vegesna; Ramashesai Besetty; Amit Kalra; Umar Farooq; Annapurna Korimilli; Keng Yu Chuang; Robert Fisher; Henry Parkman; Larry Miller
Journal:  Gastroenterol Res Pract       Date:  2010-03-18       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.